208 related articles for article (PubMed ID: 9019452)
1. [Is there an indication for intravenous iron replacement in, for example, by autologous blood donation-induced iron deficiency and is there a theoretically possible indication for intravenous administration for the not approved Ferrum Hausmann preparation?].
Kruse HJ; Creutzig A
Internist (Berl); 1996 Oct; 37(10):1059. PubMed ID: 9019452
[No Abstract] [Full Text] [Related]
2. A comparison between intravenous iron polymaltose complex (Ferrum Hausmann) and oral ferrous fumarate in the treatment of iron deficiency anaemia in pregnancy.
Singh K; Fong YF; Kuperan P
Eur J Haematol; 1998 Feb; 60(2):119-24. PubMed ID: 9508353
[TBL] [Abstract][Full Text] [Related]
3. [Autologous blood donation with preliminary erythropoietin stimulation].
Sipurzynski-Budrass S; Posch U; Stubenvoll E; Gombotz H; Lanzer G
Beitr Infusionsther Transfusionsmed; 1996; 33():201-5. PubMed ID: 8974694
[TBL] [Abstract][Full Text] [Related]
4. Clinical perspective: iron replacement therapy in chronic heart failure.
Cowie MR; Lucas R
Int J Clin Pract; 2011 Jun; 65(6):645-8. PubMed ID: 21564435
[No Abstract] [Full Text] [Related]
5. Intravenous iron sucrose versus oral iron supplementation for the treatment of iron deficiency anemia in patients with inflammatory bowel disease--a randomized, controlled, open-label, multicenter study.
Schröder O; Mickisch O; Seidler U; de Weerth A; Dignass AU; Herfarth H; Reinshagen M; Schreiber S; Junge U; Schrott M; Stein J
Am J Gastroenterol; 2005 Nov; 100(11):2503-9. PubMed ID: 16279906
[TBL] [Abstract][Full Text] [Related]
6. Intravenous versus oral iron therapy for postpartum anaemia.
Bhandal N; Russell R
BJOG; 2006 Nov; 113(11):1248-52. PubMed ID: 17004982
[TBL] [Abstract][Full Text] [Related]
7. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE; Lombraña A; Duarte P; Di Gennaro F
J Am Coll Cardiol; 2007 Oct; 50(17):1657-65. PubMed ID: 17950147
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of oral and intravenous iron therapy in haemodialysis patients.
Jenq CC; Tian YC; Wu HH; Hsu PY; Huang JY; Chen YC; Fang JT; Yang CW
Int J Clin Pract; 2008 Mar; 62(3):416-22. PubMed ID: 17511797
[TBL] [Abstract][Full Text] [Related]
9. Letter to the editor: treatment of iron deficiency anemia.
Ozsoylu S
Pediatr Hematol Oncol; 2005; 22(7):645-6; author reply 647-8. PubMed ID: 16166057
[No Abstract] [Full Text] [Related]
10. More than a decade of experience and still no consensus: controversies in iron therapy.
Besarab A
Clin J Am Soc Nephrol; 2006 Sep; 1 Suppl 1():S1-3. PubMed ID: 17699371
[No Abstract] [Full Text] [Related]
11. Slow intravenous iron administration does not aggravate oxidative stress and inflammatory biomarkers during hemodialysis: a comparative study between iron sucrose and iron dextran.
Malindretos P; Sarafidis PA; Rudenco I; Raptis V; Makedou K; Makedou A; Grekas DM
Am J Nephrol; 2007; 27(6):572-9. PubMed ID: 17804904
[TBL] [Abstract][Full Text] [Related]
12. Iron hydroxide polymaltose: iatrogenic cause of persistent iron deficiency anaemia despite continuous oral iron therapy.
Mehta BC
J Assoc Physicians India; 2002 Feb; 50():279-80. PubMed ID: 12038667
[No Abstract] [Full Text] [Related]
13. Efficacy and tolerability of intravenous ferric gluconate in the treatment of iron deficiency anemia in patients without kidney disease.
Miller HJ; Hu J; Valentine JK; Gable PS
Arch Intern Med; 2007 Jun; 167(12):1327-8. PubMed ID: 17592108
[No Abstract] [Full Text] [Related]
14. [Anaphylactic reaction after Fe-injection].
Fiechter R; Batschwaroff M; Conen D
Praxis (Bern 1994); 2005 Feb; 94(6):209-12. PubMed ID: 15754533
[TBL] [Abstract][Full Text] [Related]
15. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty.
Na HS; Shin SY; Hwang JY; Jeon YT; Kim CS; Do SH
Transfusion; 2011 Jan; 51(1):118-24. PubMed ID: 20624257
[TBL] [Abstract][Full Text] [Related]
16. Evolution of iv iron compounds over the last century.
Macdougall IC
J Ren Care; 2009 Dec; 35 Suppl 2():8-13. PubMed ID: 19891680
[TBL] [Abstract][Full Text] [Related]
17. Intravenous iron products.
Johnson CA; Mason NA; Bailie GR
ANNA J; 1999 Oct; 26(5):522-4. PubMed ID: 10776081
[TBL] [Abstract][Full Text] [Related]
18. [Parenteral iron replacement].
Cynke E
Praxis (Bern 1994); 1997 May; 86(20):835-6. PubMed ID: 9312810
[No Abstract] [Full Text] [Related]
19. The role of intravenous iron in anemia management and transfusion avoidance.
Auerbach M; Goodnough LT; Picard D; Maniatis A
Transfusion; 2008 May; 48(5):988-1000. PubMed ID: 18346021
[No Abstract] [Full Text] [Related]
20. Safety and efficacy of sodium ferric gluconate complex in iron-deficient pediatric hemodialysis patients.
Kaskel FJ
Nat Clin Pract Nephrol; 2006 May; 2(5):244-5. PubMed ID: 16932433
[No Abstract] [Full Text] [Related]
[Next] [New Search]
